Effects of combined therapy of clopidogrel and aspirin in preventing thrombus formation on mechanical heart valves in an ex vivo rabbit model.

[1]  M. Bertrand,et al.  Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting : the clopidogrel aspirin stent international cooperative study (CLASSICS). , 2000, Circulation.

[2]  J. Hirsh,et al.  Oral anticoagulation treatment in the elderly: a nested, prospective, case-control study. , 2000, Archives of internal medicine.

[3]  S. Cannegieter,et al.  Oral anticoagulant treatment in patients with mechanical heart valves: how to reduce the risk of thromboembolic and bleeding complications , 1999, Journal of internal medicine.

[4]  C. Macaya,et al.  Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients: the multicenter aspirin and ticlopidine trial after intracoronary stenting (MATTIS). , 1998, Circulation.

[5]  J. Pijoan,et al.  Prevention of thromboembolism with ticlopidine shortly after valve repair or replacement with a bioprosthesis. , 1998, The Journal of heart valve disease.

[6]  R. Falotico,et al.  The Antiaggregating and Antithrombotic Activity of Clopidogrel Is Potentiated by Aspirin in Several Experimental Models in the Rabbit , 1998, Thrombosis and Haemostasis.

[7]  K. Bailey,et al.  Variability in anticoagulation control predicts thromboembolism after mechanical cardiac valve replacement: a 23-year population-based study. , 1997, Mayo Clinic proceedings.

[8]  M. Hsin,et al.  ANTICOAGULANT CONTROL IN THE FIRST THREE MONTHS AFTER MECHANICAL HEART VALVE REPLACEMENT , 1997, International journal of clinical practice.

[9]  M. Hadamitzky,et al.  Major benefit from antiplatelet therapy for patients at high risk for adverse cardiac events after coronary Palmaz-Schatz stent placement: analysis of a prospective risk stratification protocol in the Intracoronary Stenting and Antithrombotic Regimen (ISAR) trial. , 1997, Circulation.

[10]  V. Fuster,et al.  Characterization of a tubular flow chamber for studying platelet interaction with biologic and prosthetic materials: deposition of indium 111-labeled platelets on collagen, subendothelium, and expanded polytetrafluoroethylene. , 1987, The Journal of laboratory and clinical medicine.

[11]  J. Matloff,et al.  Comparative clinical experience with porcine bioprosthetic and St. Jude valve replacement. , 1987, Chest.

[12]  P. Ribeiro,et al.  Antiplatelet drugs and the incidence of thromboembolic complications of the St. Jude Medical aortic prosthesis in patients with rheumatic heart disease. , 1986, The Journal of thoracic and cardiovascular surgery.

[13]  W. Bossert,et al.  Vesicular transport across endothelium: simulation of a diffusion model. , 1969, Journal of theoretical biology.